- Home
- SBT vs INBX Comparison
SBT vs INBX Comparison
Compare SBT & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBT
- INBX
- Stock Information
- Founded
- SBT 1984
- INBX 2010
- Country
- SBT United States
- INBX United States
- Employees
- SBT N/A
- INBX N/A
- Industry
- SBT Savings Institutions
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- SBT Finance
- INBX Health Care
- Exchange
- SBT Nasdaq
- INBX Nasdaq
- Market Cap
- SBT 253.2M
- INBX 218.9M
- IPO Year
- SBT 2017
- INBX 2020
- Fundamental
- Price
- SBT $4.77
- INBX $13.92
- Analyst Decision
- SBT
- INBX Hold
- Analyst Count
- SBT 0
- INBX 1
- Target Price
- SBT N/A
- INBX N/A
- AVG Volume (30 Days)
- SBT 27.7K
- INBX 71.1K
- Earning Date
- SBT 01-22-2025
- INBX 11-14-2024
- Dividend Yield
- SBT N/A
- INBX N/A
- EPS Growth
- SBT N/A
- INBX N/A
- EPS
- SBT 0.12
- INBX 119.38
- Revenue
- SBT $67,988,000.00
- INBX $1,568,000.00
- Revenue This Year
- SBT N/A
- INBX N/A
- Revenue Next Year
- SBT $6.68
- INBX N/A
- P/E Ratio
- SBT $39.94
- INBX $0.12
- Revenue Growth
- SBT N/A
- INBX 19.24
- 52 Week Low
- SBT $4.40
- INBX $10.80
- 52 Week High
- SBT $5.97
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- SBT 45.25
- INBX 38.33
- Support Level
- SBT $4.71
- INBX $14.53
- Resistance Level
- SBT $4.87
- INBX $15.24
- Average True Range (ATR)
- SBT 0.04
- INBX 0.72
- MACD
- SBT -0.01
- INBX -0.10
- Stochastic Oscillator
- SBT 37.50
- INBX 19.16
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.